DataMeds outlines peptide compounding plans after FDA policy proposal
Go back to DataMeds outlines peptide compounding plans after FDA policy proposal| (NASDAQ: DVLT) | Delayed: 0.13 -0.01 (7.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.14 | 52 Week High | $ | |||
| Open | $0.14 | 52 Week Low | $ | |||
| Day High | $0.14 | P/E | N/A | |||
| Day Low | $0.13 | EPS | $ | |||
| Volume | 18,344,180 | |||||
| Medistem, Inc. (NASDAQ: MEDS) | Delayed: 2.63 -0.22 (7.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.85 | 52 Week High | $2.80 | |||
| Open | $2.80 | 52 Week Low | $0.08 | |||
| Day High | $2.86 | P/E | N/A | |||
| Day Low | $2.62 | EPS | $0.00 | |||
| Volume | 309,266 | |||||



